Industry Insights

Biotech Funding: Why ADCs Became VC Magnets in 2024

4 February 2025 - Antibody-Drug Conjugates (ADC)-focused biotech companies have surged back into the spotlight in 2024, attracting significant venture capital (VC) funding values and volumes.

The Drug Modality and Therapeutic Area Trends of 2024.

17 October 2024 - From the perennial favourites like oncology to the booming fields of ADC and GLP-1, our latest report explores Big Pharma’s favourite drug modalities and therapeutic areas for M&A.

Report

Top 10 Pharma Companies: M&A Trends and Outlook for 2024

11 June 2024 - With revenue challenges lying ahead and plenty of cash available, Pharma top 10 is expected to increasingly turn towards M&A to secure growth in the future.

Report

8 Criteria VCs Evaluate Before Funding Biotech in 2024

15 May 2024 - Based on our survey with 50+ prominent Venture Capitalists, we have identified 8 criteria that shape how biopharma-focused VCs evaluate potential Biotech funding in 2024.

Survey

Organ-on-a-chip: Thumb-sized Organs, Huge Potential For Pharma R&D

25 January 2024 - Discover what impact organ-on-a-chip could have on drug development and how Pharma stakeholders are investing to realise its true potential.

Article

Circular RNA: Could RNA Rings Become Pharma’s New Jewel?

13 November 2023 - Pharma is betting big on circular RNA to be the next generation of therapies. Here is, in a nutshell, why you should keep an eye on this exciting technology.

Article